vTv Therapeutics (VTVT) Operating Leases (2019 - 2025)
Historic Operating Leases for vTv Therapeutics (VTVT) over the last 7 years, with Q1 2025 value amounting to $125000.0.
- vTv Therapeutics' Operating Leases fell 5805.37% to $125000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $125000.0, marking a year-over-year decrease of 5805.37%. This contributed to the annual value of $169000.0 for FY2024, which is 0.0% changed from last year.
- Latest data reveals that vTv Therapeutics reported Operating Leases of $125000.0 as of Q1 2025, which was down 5805.37% from $169000.0 recorded in Q4 2024.
- Over the past 5 years, vTv Therapeutics' Operating Leases peaked at $633000.0 during Q1 2021, and registered a low of $125000.0 during Q1 2025.
- Over the past 5 years, vTv Therapeutics' median Operating Leases value was $417000.0 (recorded in 2023), while the average stood at $390470.6.
- In the last 5 years, vTv Therapeutics' Operating Leases soared by 294.78% in 2023 and then crashed by 5805.37% in 2025.
- Over the past 5 years, vTv Therapeutics' Operating Leases (Quarter) stood at $492000.0 in 2021, then crashed by 31.3% to $338000.0 in 2022, then tumbled by 50.0% to $169000.0 in 2023, then changed by 0.0% to $169000.0 in 2024, then decreased by 26.04% to $125000.0 in 2025.
- Its last three reported values are $125000.0 in Q1 2025, $169000.0 for Q4 2024, and $213000.0 during Q3 2024.